{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:29:28Z","timestamp":1748302168284,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Danish Cancer Society\u2019s Scientific Committee","award":["R146-A9249-16-S2"],"award-info":[{"award-number":["R146-A9249-16-S2"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0052346"],"award-info":[{"award-number":["NNF18OC0052346"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010809","name":"Jascha Fonden","doi-asserted-by":"publisher","award":["5570"],"award-info":[{"award-number":["5570"]}],"id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["10-001599"],"award-info":[{"award-number":["10-001599"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10552-020-01372-3","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T03:03:18Z","timestamp":1609729398000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endometrial cancer risk after fertility treatment: a population-based cohort study"],"prefix":"10.1007","volume":"32","author":[{"given":"Sonia","family":"Guleria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanna","family":"Albieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bugge","family":"N\u00f8hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne K.","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"6","key":"1372_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"1372_CR2","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31(20):2607\u20132618","journal-title":"J Clin Oncol"},{"issue":"3","key":"1372_CR3","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/bcr3206","volume":"14","author":"ME Jones","year":"2012","unstructured":"Jones ME, van Leeuwen FE, Hoogendoorn WE et al (2012) Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast Cancer Res 14(3):R91","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1372_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10552-014-0350-1","volume":"25","author":"AS Felix","year":"2014","unstructured":"Felix AS, Yang HP, Gierach GL, Park Y, Brinton LA (2014) Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control 25(4):479\u2013489","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1372_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/aje\/kwi084","volume":"161","author":"MD Althuis","year":"2005","unstructured":"Althuis MD, Moghissi KS, Westhoff CL et al (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161(7):607\u2013615","journal-title":"Am J Epidemiol"},{"issue":"11","key":"1372_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/oxfordjournals.aje.a009397","volume":"147","author":"B Modan","year":"1998","unstructured":"Modan B, Ron E, Lerner-Geva L et al (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147(11):1038\u20131042","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1372_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0015-0282(99)00085-0","volume":"71","author":"G Potashnik","year":"1999","unstructured":"Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71(5):853\u2013859","journal-title":"Fertil Steril"},{"issue":"11","key":"1372_CR8","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","volume":"100","author":"S Silva Idos","year":"2009","unstructured":"Silva Idos S, Wark PA, McCormack VA et al (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 100(11):1824\u20131831","journal-title":"Br J Cancer"},{"issue":"10","key":"1372_CR9","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/humrep\/det323","volume":"28","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Westhoff CL, Scoccia B et al (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod 28(10):2813\u20132821","journal-title":"Hum Reprod"},{"issue":"8","key":"1372_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","volume":"17","author":"P Doyle","year":"2002","unstructured":"Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL (2002) Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17(8):2209\u20132213","journal-title":"Hum Reprod"},{"key":"1372_CR11","doi-asserted-by":"publisher","first-page":"k2644","DOI":"10.1136\/bmj.k2644","volume":"362","author":"CL Williams","year":"2018","unstructured":"Williams CL, Jones ME, Swerdlow AJ et al (2018) Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991\u20132010: data linkage study including 2.2 million person years of observation. BMJ 362:k2644","journal-title":"BMJ"},{"issue":"8","key":"1372_CR12","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/humrep\/dev124","volume":"30","author":"MM Reigstad","year":"2015","unstructured":"Reigstad MM, Larsen IK, Myklebust TA et al (2015) Cancer risk among parous women following assisted reproductive technology. Hum Reprod 30(8):1952\u20131963","journal-title":"Hum Reprod"},{"issue":"9190","key":"1372_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","volume":"354","author":"A Venn","year":"1999","unstructured":"Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354(9190):1586\u20131590","journal-title":"Lancet"},{"issue":"3","key":"1372_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R Calderon-Margalit","year":"2009","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 169(3):365\u2013375","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1372_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3109\/09513590.2012.671391","volume":"28","author":"L Lerner-Geva","year":"2012","unstructured":"Lerner-Geva L, Rabinovici J, Olmer L, Blumstein T, Mashiach S, Lunenfeld B (2012) Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol 28(10):809\u2013814","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"1372_CR16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/aje\/kwp290","volume":"170","author":"A Jensen","year":"2009","unstructured":"Jensen A, Sharif H, Kjaer SK (2009) Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 170(11):1408\u20131414","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1372_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","volume":"77","author":"J Dor","year":"2002","unstructured":"Dor J, Lerner-Geva L, Rabinovici J et al (2002) Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 77(2):324\u2013327","journal-title":"Fertil Steril"},{"issue":"1","key":"1372_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00432-015-2035-x","volume":"142","author":"R Kessous","year":"2016","unstructured":"Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E (2016) The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. J Cancer Res Clin Oncol 142(1):287\u2013293","journal-title":"J Cancer Res Clin Oncol"},{"key":"1372_CR19","doi-asserted-by":"crossref","unstructured":"Skalkidou A, Sergentanis TN, Gialamas SP et al (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database Syst Rev 3:Cd010931","DOI":"10.1002\/14651858.CD010931.pub2"},{"key":"1372_CR20","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2019. https:\/\/www.whocc.no\/filearchive\/publications\/2019_guidelines_web.pdf"},{"key":"1372_CR21","unstructured":"R Core Team (2013) R: a language and environment for statistical computing. https:\/\/www.R-project.org"},{"issue":"6","key":"1372_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/CEJ.0b013e32833d9388","volume":"19","author":"F Parazzini","year":"2010","unstructured":"Parazzini F, Pelucchi C, Talamini R, Montella M, La Vecchia C (2010) Use of fertility drugs and risk of endometrial cancer in an Italian case\u2013control study. Eur J Cancer Prev 19(6):428\u2013430","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"1372_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/humrep\/16.1.196","volume":"16","author":"F Parazzini","year":"2001","unstructured":"Parazzini F, Ricci E, Rosa C, Negri E, La Vecchia C (2001) Risk of endometrial cancer after use of fertility drugs. Hum Reprod 16(1):196","journal-title":"Hum Reprod"},{"issue":"1","key":"1372_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-2115(01)00344-X","volume":"98","author":"A Benshushan","year":"2001","unstructured":"Benshushan A, Paltiel O, Brzezinski A et al (2001) Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol 98(1):53\u201357","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 5","key":"1372_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1289\/ehp.93101s5137","volume":"101","author":"S Preston-Martin","year":"1993","unstructured":"Preston-Martin S, Pike MC, Ross RK, Henderson BE (1993) Epidemiologic evidence for the increased cell proliferation model of carcinogenesis. Environ Health Perspect 101(Suppl 5):137\u2013138","journal-title":"Environ Health Perspect"},{"issue":"2","key":"1372_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0015-0282(97)81907-3","volume":"67","author":"Y Nakamura","year":"1997","unstructured":"Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67(2):256\u2013260","journal-title":"Fertil Steril"},{"issue":"1","key":"1372_CR27","first-page":"35","volume":"23","author":"E Miannay","year":"1994","unstructured":"Miannay E, Boutemy JJ, Leroy-Billiard M, Gasnault JP, Leroy JL (1994) The possible endometrial risk of ovarian stimulation. J Gynecol Obstet Biol Reprod (Paris) 23(1):35\u201338","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5","key":"1372_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","volume":"99","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G (2013) In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril 99(5):1189\u20131196","journal-title":"Fertil Steril"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01372-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-020-01372-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01372-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T20:57:38Z","timestamp":1610744258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-020-01372-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s10552-020-01372-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}